Induction and concurrent chemoradiotherapy for non-small cell lung cancer (NSCLC) using cisplatin and vinorelbine

被引：0
|
作者：
Ho, G. Fuang [1 ]
Popat, S. [2 ]
Nutting, C. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Clin Oncol, London SW3 6JJ, England
[2] Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England
来源：
LUNG CANCER | 2008年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Concurrent Chemoradiotherapy with Biweekly Gemcitabine and Cisplatin in Patients with Locally Advanced Non-small Cell Lung Cancer
    Oak, Chul Ho
    Kim, Ja Kyung
    La Jang, Lee
    Moon, Dae Sung
    Jang, Tae Won
    Jung, Maan Hong
    Cho, Sung Whan
    Jeung, Tae Sig
    RADIATION ONCOLOGY JOURNAL, 2008, 26 (03): : 160 - 165
  • [32] Induction chemotherapy (CT) followed by accelerated radiotherapy and concurrent cisplatin in locally advanced non-small cell lung cancer (NSCLC)
    Arriagada, R
    Kleinman, S
    Orlandi, L
    Roth, B
    del Castillo, C
    Gutiérrez, J
    Zuñiga, M
    Baeza, R
    LUNG CANCER, 2005, 49 : S165 - S165
  • [33] Gemcitabin, cisplatin (GP) versus vinorelbine, ifosfamide, cisplatin (NIP) in locally advanced non-small cell lung cancer (NSCLC)
    Certíková, G
    Eliasová, B
    Pesek, M
    LUNG CANCER: CURRENT TOPICS, 2001, : 103 - 108
  • [34] Gemcitabine/vinorelbine/cisplatin in patients with advanced non-small cell lung cancer
    Doweik, L
    Pohl, G
    Malayeri, R
    Krajnik, G
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 263 - 266
  • [35] Induction therapy for non-small cell lung cancer (NSCLC)
    Nakamura, H
    Furukawa, K
    Ikeda, N
    Shibuya, H
    Tanaka, K
    Okunaka, T
    Hirano, T
    Sakai, M
    Saito, M
    Konaka, C
    Kato, H
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
  • [36] Cisplatin, ifosfamide and vinorelbine combination in advanced non-small cell lung cancer
    Baron, FJ
    Cueva, JF
    Vazquez, F
    Candamio, S
    Calvo, M
    Sanz, A
    Irigoyen, A
    Menendez, MD
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [37] Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer
    Barone, C
    Corsi, DC
    Pozzo, C
    Cassano, A
    Alvaro, G
    Colloca, G
    Landriscina, M
    Astone, A
    ONCOLOGY, 2000, 58 (01) : 25 - 30
  • [38] Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer
    Liu, Di
    Zheng, Xiao
    Chen, Jiayan
    Liu, Guan
    Xu, Yaping
    Shen, Yuxin
    Xie, Liyi
    Zhao, Weixin
    Jiang, Guoliang
    Fan, Min
    LUNG CANCER, 2015, 89 (03) : 249 - 254
  • [39] Concurrent chemoradiotherapy with weekly cisplatin in stage III unresectable non-small cell lung cancer (NSCLC): A local experience with LATAM patients.
    Salinas, Carlos
    Pinto Negrete, Felipe Eduardo
    Paz Saavedra, Maria
    Orlandi, Francisco J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
12345